Antisoma plc: Result of Antisoma Annual General Meeting | Company Announcements

Tuesday 10 November, 2009

Antisoma plc

Result of Antisoma Annual General Meeting





10 November 2009, London, UK, and Cambridge, MA: Antisoma plc  (LSE:
ASM; USOTC: ATSMY) announces that all resolutions at today's Annual
General Meeting were passed. Details of proxy votes relating to the
resolutions set out in the AGM Notice can be viewed on the Antisoma
website at www.antisoma.com/asm/ir/shareinfo/meetings/

In accordance with Listing Rule 9.6.3(1), two copies of the
resolutions (other than those resolutions comprising ordinary
business) passed by the Company at the Annual General Meeting held
today have been lodged with the UK Listing Authority for publication
through the Document Viewing Facility situated at Financial Services
Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS.

Enquiries:
Daniel Elger, VP Marketing & Communications
Antisoma plc
+44 (0) 7909 915 068

Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company
that develops novel products for the treatment of cancer. The Company
has operations in the UK and the US. Please visit www.antisoma.com
for further information about Antisoma.

---END OF MESSAGE---




This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.